Published in Epilepsia on March 01, 2007
Generic antiepileptic drugs: current controversies and future directions. Epilepsy Curr (2008) 1.13
Interchangeability of generic anti-epileptic drugs: a quantitative analysis of topiramate and gabapentin. Eur J Clin Pharmacol (2011) 0.84
Understanding patients' perspective in the use of generic antiepileptic drugs: compelling lessons for physicians to improve physician/patient communication. BMC Neurol (2009) 0.79
Requirements for generic anti-epileptic medicines: a regulatory perspective. J Neurol (2009) 0.75
15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet (2009) 6.21
Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain (2009) 3.96
Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305. Epilepsia (2012) 2.63
Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes. Am J Hum Genet (2010) 2.61
Focal cortical dysplasias: surgical outcome in 67 patients in relation to histological subtypes and dual pathology. Brain (2004) 2.46
Targeted next generation sequencing as a diagnostic tool in epileptic disorders. Epilepsia (2012) 2.45
Long-term seizure outcome in 211 patients with focal cortical dysplasia. Epilepsia (2014) 2.17
Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biol Psychiatry (2006) 2.17
Vagus nerve stimulation for drug-resistant epilepsy: a European long-term study up to 24 months in 347 children. Epilepsia (2014) 2.15
Cavernoma-related epilepsy: review and recommendations for management--report of the Surgical Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia (2013) 2.00
Epilepsy, hippocampal sclerosis and febrile seizures linked by common genetic variation around SCN1A. Brain (2013) 1.95
Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol (2009) 1.73
Common genetic variation and susceptibility to partial epilepsies: a genome-wide association study. Brain (2010) 1.67
Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes. Nat Genet (2013) 1.59
Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16.1, 2q22.3 and 17q21.32. Hum Mol Genet (2012) 1.48
Is there evidence for clinical differences related to the new classification of temporal lobe cortical dysplasia? Epilepsia (2013) 1.43
The influence of antiepileptic drugs on cognition: a comparison of levetiracetam with topiramate. Epilepsy Behav (2007) 1.31
Multi-focal occurrence of cortical dysplasia in epilepsy patients. Brain (2009) 1.30
Modern technology calls for a modern approach to classification of epileptic seizures and the epilepsies. Epilepsia (2012) 1.24
DEPDC5 mutations in genetic focal epilepsies of childhood. Ann Neurol (2014) 1.21
Clinical characteristics in focal cortical dysplasia: a retrospective evaluation in a series of 120 patients. Brain (2006) 1.20
A GABRB3 promoter haplotype associated with childhood absence epilepsy impairs transcriptional activity. Hum Mol Genet (2006) 1.16
Therapeutic drug monitoring of the newer antiepileptic drugs. Ther Drug Monit (2003) 1.15
Neuropathologic measurements in focal cortical dysplasias: validation of the ILAE 2011 classification system and diagnostic implications for MRI. Acta Neuropathol (2011) 1.11
Comparison of brain extracellular fluid, brain tissue, cerebrospinal fluid, and serum concentrations of antiepileptic drugs measured intraoperatively in patients with intractable epilepsy. Epilepsia (2006) 1.10
Continuous phenobarbital treatment leads to recurrent plantar fibromatosis. Epilepsia (2008) 1.10
Management and long-term outcome in patients presenting with ictal asystole or bradycardia. Epilepsia (2011) 1.09
Suicidality, psychopathology, and gender in incarcerated adolescents in Austria. J Clin Psychiatry (2007) 1.06
Consensus on diagnosis and management of JME: From founder's observations to current trends. Epilepsy Behav (2013) 1.01
Disconnective surgery in posterior quadrantic epilepsy: experience in a consecutive series of 10 patients. Neurosurg Focus (2013) 0.97
Everolimus in tuberous sclerosis patients with intractable epilepsy: a treatment option? Eur J Paediatr Neurol (2013) 0.97
Seizure anticipation by patients with focal and generalized epilepsy: a multicentre assessment of premonitory symptoms. Epilepsy Res (2006) 0.95
Predictors for negative attitudes toward subjects with epilepsy: a representative survey in the general public in Austria. Epilepsia (2005) 0.95
Genome-wide linkage meta-analysis identifies susceptibility loci at 2q34 and 13q31.3 for genetic generalized epilepsies. Epilepsia (2012) 0.94
Real-time, in vivo monitoring and pharmacokinetics of valproic acid via a novel biomarker in exhaled breath. Chem Commun (Camb) (2011) 0.91
Speech and school performance in children with benign partial epilepsy with centro-temporal spikes (BCECTS). Seizure (2009) 0.90
Tolerability of levetiracetam in elderly patients with CNS disorders. Epilepsy Res (2003) 0.89
Long-term outcome and tolerability of the ketogenic diet in drug-resistant childhood epilepsy--the Austrian experience. Seizure (2010) 0.89
Neuropsychological and psychiatric impact of add-on titration of pregabalin versus levetiracetam: a comparative short-term study. Epilepsy Behav (2006) 0.88
Chronic high-frequency deep-brain stimulation in progressive myoclonic epilepsy in adulthood--report of five cases. Epilepsia (2011) 0.88
A randomized, double-blind comparison of antiepileptic drug treatment in the elderly with new-onset focal epilepsy. Epilepsia (2015) 0.87
E-learning courses in epilepsy--concept, evaluation, and experience with the e-learning course "genetics of epilepsies". Epilepsia (2007) 0.87
The safety and efficacy of add-on levetiracetam in elderly patients with focal epilepsy: a one-year observational study. Seizure (2011) 0.87
Linkage and association analysis of CACNG3 in childhood absence epilepsy. Eur J Hum Genet (2007) 0.86
Linkage and mutational analysis of CLCN2 in childhood absence epilepsy. Epilepsy Res (2007) 0.86
Effects of an inpatient rehabilitation program after temporal lobe epilepsy surgery and other factors on employment 2 years after epilepsy surgery. Epilepsia (2014) 0.86
Evaluation of CACNA1H in European patients with childhood absence epilepsy. Epilepsy Res (2006) 0.86
Levetiracetam vs. sulthiame in benign epilepsy with centrotemporal spikes in childhood: a double-blinded, randomized, controlled trial (German HEAD Study). Eur J Paediatr Neurol (2013) 0.86
Beneficial effect of epilepsy surgery in a case of childhood non-paraneoplastic limbic encephalitis. Epilepsy Res (2010) 0.86
State and trait emotions in delinquent adolescents. Child Psychiatry Hum Dev (2007) 0.85
Diagnostic problems during late course in Creutzfeldt-Jakob disease. J Neurol (2003) 0.85
Sex-specific predictors of criminal recidivism in a representative sample of incarcerated youth. Compr Psychiatry (2008) 0.85
Adaptive behaviour in Down syndrome: a cross-sectional study from childhood to adulthood. Wien Klin Wochenschr (2010) 0.85
Vertical perithalamic hemispherotomy: a single-center experience in 40 pediatric patients with epilepsy. Epilepsia (2013) 0.84
Genome wide high density SNP-based linkage analysis of childhood absence epilepsy identifies a susceptibility locus on chromosome 3p23-p14. Epilepsy Res (2009) 0.84
Long-term follow-up of patients with congenital hyperinsulinism in Austria. J Pediatr Endocrinol Metab (2008) 0.84
Glutamate decarboxylase 67 is expressed in hippocampal mossy fibers of temporal lobe epilepsy patients. Hippocampus (2011) 0.84
Dynamic up-regulation of prodynorphin transcription in temporal lobe epilepsy. Hippocampus (2009) 0.84
Frameless stereotactic drilling for placement of depth electrodes in refractory epilepsy: operative technique and initial experience. Neurosurgery (2014) 0.84
Frontal delta power associated with negative symptoms in ultra-high risk individuals who transitioned to psychosis. Schizophr Res (2012) 0.84
Neuropsychological performance in frontal lobe epilepsy. Seizure (2002) 0.83
Analysis of ELP4, SRPX2, and interacting genes in typical and atypical rolandic epilepsy. Epilepsia (2014) 0.82
Selective amygdalohippocampectomy versus standard temporal lobectomy in patients with mesial temporal lobe epilepsy and unilateral hippocampal sclerosis. Epilepsy Res (2012) 0.82
Topiramate: a prospective study on the relationship between concentration, dosage and adverse events in epileptic patients on combination therapy. Epileptic Disord (2005) 0.82
Determinants of quality of life in patients with refractory focal epilepsy who were not eligible for surgery or who rejected surgery. Epilepsy Behav (2012) 0.82
Remote memory in temporal lobe epilepsy. Epilepsia (2006) 0.81
Clinical findings in sporadic Creutzfeldt-Jakob disease correlate with thalamic pathology. Brain (2002) 0.81
Type 1 diabetes and epilepsy: efficacy and safety of the ketogenic diet. Epilepsia (2010) 0.81
Tuberous Sclerosis Complex: new criteria for diagnostic work-up and management. Wien Klin Wochenschr (2015) 0.81
Smoking reduces serum levels of lamotrigine. Seizure (2008) 0.81
Ictal autoscopic phenomena and near death experiences: a study of five patients with ictal autoscopies. J Neurol (2012) 0.81
"Tell me how do I feel"--emotion recognition and theory of mind in symptomatic mesial temporal lobe epilepsy. Neuropsychologia (2011) 0.81
Genomic microdeletions associated with epilepsy: not a contraindication to resective surgery. Epilepsia (2011) 0.81
The effects of cognitive rehabilitation on memory outcome after temporal lobe epilepsy surgery. Epilepsy Behav (2007) 0.81
Relationship between lamotrigine oral dose, serum level and its inhibitory effect on CNS: insights from transcranial magnetic stimulation. Epilepsy Res (2003) 0.81
Prospective study on concentration-efficacy and concentration-toxicity: correlations with lamotrigine serum levels. Epileptic Disord (2002) 0.81
Long-term antiepileptic treatment with histone deacetylase inhibitors may reduce the risk of prostate cancer. Eur J Cancer Prev (2012) 0.81
Myoclonic astatic epilepsy (Doose syndrome) - a lamotrigine responsive epilepsy? Eur J Paediatr Neurol (2012) 0.81
Semiology of temporal lobe epilepsy in children and adolescents. Value in lateralizing the seizure onset zone [corrected]. Epilepsy Res (2002) 0.80
Trigeminal evoked potentials and sensory deficits in atypical facial pain--a comparison with results in trigeminal neuralgia. Funct Neurol (2003) 0.80
Prevalence of anxiety disorders in patients with refractory focal epilepsy--a prospective clinic based survey. Epilepsy Behav (2010) 0.80
Levetiracetam-induced myoclonic status epilepticus in myoclonic-astatic epilepsy: a case report. Epileptic Disord (2006) 0.80
Alterations in functional connectivity of the amygdala in unilateral mesial temporal lobe epilepsy. J Neurol (2012) 0.79
Perioral reflex myoclonias: a controlled study in patients with JME and focal epilepsies. Epilepsia (2006) 0.79
Do antiepileptic drugs accelerate forgetting? Epilepsy Behav (2005) 0.79
Hypothalamic hamartoma: is the epileptogenic zone always hypothalamic? Arguments for independent (third stage) secondary epileptogenesis. Epilepsia (2013) 0.79
Hyperkinetic seizures in patients with temporal lobe epilepsy: clinical features and outcome after temporal lobe resection. Epilepsia (2011) 0.79
Combined electroencephalography and magnetoencephalography of interictal spikes in benign rolandic epilepsy of childhood. Clin Neurophysiol (2008) 0.79
Automated morphometric magnetic resonance imaging analysis for the detection of periventricular nodular heterotopia. Epilepsia (2013) 0.79
Fluctuation of lacosamide serum concentrations during the day and occurrence of adverse drug reactions--first clinical experience. Epilepsy Res (2011) 0.78
Juvenile myoclonic epilepsy with photosensitivity in a female with Velocardiofacial syndrome (del(22)(q11.2))--causal relationship or coincidence? Seizure (2009) 0.78
Long-term outcome of difficult-to-treat epilepsy in childhood. Neuropediatrics (2010) 0.78
Epilepsy, behavior, and art (Epilepsy, Brain, and Mind, part 1). Epilepsy Behav (2013) 0.78
The expanding mutational spectrum of MERRF substitution G8361A in the mitochondrial tRNALys gene. Ann Neurol (2003) 0.77
Add-on lacosamide: a retrospective study on the relationship between serum concentration, dosage, and adverse events. Epilepsy Behav (2011) 0.77